Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...

Gov. Jeff Landry’s proposed tax policy revamp went through further changes Tuesday in the Louisiana Legislature, with ...

Emmaus Life Sciences, Inc. ( OTCQB : EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, greetings, and welcome to the KORU Medical ...

Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what ...

The reactions to Donald's Trump's victory across the crypto, currency, and stock markets. Super Micro's woes, and the outlook for a company with no auditor, no annual report and, perhaps soon, no ...

NASDAQ:HROW) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsJamie Webb - Director, Communications ...

FDA approval of MIPLYFFA™ and product launch cap third quarter filled with multiple commercial and clinical development milestonesZevra received ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...

Q3 2024 Earnings Call Transcript November 14, 2024 Sensus Healthcare, Inc. beats earnings expectations. Reported EPS is $0.07 ...

The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, increased approximately 14% versus net Q2 2024 revenue of $2.7 ...

“Children’s Product” does not include the following things: (1) batteries; (2) consumer electronic products; (3) a food or beverage or an additive to a food and beverage regulated by the FDA; or (4) a ...